The data items required for National Cancer Data Standards for Wales – Site Specific – Colorectal and their equivalent labels in COSD V9.0, where there is an equivalent, are listed below.
Where the specification cites NHS Wales Data Dictionary, please refer to the Dictionary for the relevant guidance i.e. definition, format, or code list.
For consistency, all dates listed in the Specification are standardised as ccyymmdd.
Where D is denoted in Status, this indicates that the information should be derived from another data item. This typically occurs with data items that are simply text representations of their code counterparts. Other Status codes are M (Mandatory), R (Required) – the data item should be recorded where applicable and O (Optional).
Core data items should be collected for all cancers. To reduce replication of information, Core data items have not been listed in this site-specific Standard and users should refer to National Cancer Data Standards for Wales – 1. National Cancer Data Set - Full list DSCNs.xlsx (live.com) for a list of Core requirements. However, in some cases, the site-specific application of Core data items may differ e.g. a particular tumour site may require additional or fewer codes to those already published in Core, or perhaps have additional business rules as to how the Core data item should be coded. Where this occurs, the Core data item will be replicated in the site-specific Standard with the respective additional site-specific detail. These are flagged in the following table with an * next to the data item name.
For data items used in the National Cancer Data Standards for Wales that already exist within the NHS Wales Data Dictionary. These data items have been flagged with an † next to the data item name, as whilst this introduces a change to an existing information standard, the immediate use of this mandate will be used as a framework for the development of the CIS, therefore service/data providers should continue with ‘business as usual’ in terms of the data being collected and reported.
National Cancer Data Standards for Wales– Colorectal
Reporting Data Item |
Definition |
Format |
Code List |
Code List (Text) |
Status |
COSD |
Colorectal - Diagnosis. To carry diagnostic details for Colorectal cancer (One occurrence per core diagnosis group) | ||||||
Synchronous Tumour Indicator |
Record any synchronous tumours in the Colon as
identified by the clinician at presentation. |
Code List |
01 |
Caecum |
R |
Synchronous Tumour Indicator (CO5400) |
02 |
Appendix | |||||
03 |
Ascending Colon | |||||
04 |
Hepatic Flexure | |||||
05 |
Transverse Colon | |||||
06 |
Splenic Flexure | |||||
07 |
Descending Colon | |||||
08 |
Sigmoid Colon | |||||
09 |
Rectosigmoid | |||||
10 |
Rectum | |||||
Tumour Height Above Anal Verge |
Record the approximate height in centimetres of the
lower limit of the tumour above anal verge as measured by rigid
sigmoidoscopy only. |
max n2 |
N/A |
N/A |
R |
Tumour Height Above Anal Verge (CO5160) |
Pre-habilitation Programme Status |
Did the patient undergo a formal pre-habilitation programme |
Code List |
Y |
Yes |
R |
N/A |
N |
No | |||||
9 |
Not Known | |||||
Cardiopulmonary Test Type |
Indicate which
cardiopulmonary test was used |
Code List |
1 |
Incremental shuttle walk test (ISWT) |
R |
Cardiopulmonary Test Type (LU10420) |
2 |
Oxygen consumption (VO2) | |||||
Cardiopulmonary Exercise Test Result |
The Cardiopulmonary Exercise
Test result |
max n3 |
N/A |
N/A |
R |
Cardiopulmonary Exercise Test Result (NLCA) (LU10370) |
Cardiopulmonary Exercise Testing (CPEX) Anaerobic Threshold |
Record the anaerobic threshold |
max n2.max n1 |
N/A |
N/A |
R |
N/A |
Mismatch Repair Proteins |
An indication of the
presence or absence of mismatch repair proteins in the
cancer |
Code List |
1 |
Deficient |
R |
N/A |
2 |
Proficient | |||||
Colorectal - Clinical Nurse Specialist. To carry details of Clinical Nurse Specialist Type (Multiple occurrences as per Core - CNS & Risk Factor Group) | ||||||
Clinical Nurse Specialist Type |
The type of clinical Nurse Specialist assigned to the patient during their treatment pathway |
Code List |
1 |
Clinical Nurse Specialist |
R |
Clinical Nurse Specialist Type (CO5180) |
2 |
Stoma Nurse Specialist | |||||
8 |
Other | |||||
9 |
Not Known | |||||
Colorectal - Surgery. To carry additional surgery details for Colorectal cancer (One occurrence per core surgery group) | ||||||
Reason for No Surgical Treatment |
The reason why surgical treatment was not carried out |
Code List |
1 |
Patient unfit due to a pre-diagnosed medical condition |
R |
N/A |
2 |
Patient refused treatment | |||||
3 |
Advanced disease | |||||
7 |
Other | |||||
Reason for No Surgical Treatment - 'Other' |
If Other is recorded for data item Reason for No Surgical Treatment, please specify the reason why surgical treatment was not carried out |
max an100 |
N/A |
N/A |
R |
N/A |
Consultant Code - Surgical Treatment |
The GMC code for the
Consultant who was actually in overall charge of the patient’s surgical
treatment during the time the patient was in hospital undergoing
surgery |
an8 |
N/A |
N/A |
R |
N/A |
Surgical Admission Type * |
Record the mode of surgery
performed |
Code List |
1 |
Elective |
R |
Surgical Admission Type (CR8500) |
2 |
Emergency | |||||
3 |
Scheduled/Expedited | |||||
4 |
Urgent | |||||
9 |
Not Known | |||||
Surgical Access Type * |
Approach to surgery
(laparoscopic, thoracoscopic, open, |
Code List |
1 |
Open operation |
R |
Surgical Access Type (CR6310) |
3 |
Laparoscopic/Thoracoscopic with unplanned conversion to open surgery | |||||
4 |
Laparoscopic/Thoracoscopic completed | |||||
5 |
Trans Anal (For TME excisions) | |||||
Z |
Not applicable | |||||
Stoma |
Specify the type of stoma created |
Code List |
1 |
Ileostomy temporary |
R |
N/A |
2 |
Ileostomy permanent | |||||
3 |
Colostomy temporary | |||||
4 |
Colostomy permanent | |||||
Surgical Complications |
Any complications relevant
to the surgical treatments that the patient has received (during primary
treatment period) |
Code List |
1 |
Leak |
R |
N/A |
2 |
Abscess | |||||
3 |
Bleed | |||||
4 |
Obstruction | |||||
5 |
Stoma malfunction | |||||
6 |
Readmission (within 14 days of surgical procedure) | |||||
7 |
Other | |||||
Surgical Complications - 'Other' |
If Other is recorded
for data item Surgical Complications, please specify the surgical
complications relevant to the surgical treatments that the patient has
received |
max an100 |
N/A |
N/A |
R |
N/A |
Cancer Treatment Curability |
The Surgeons opinion of the
completeness of the excision based on clinical findings at the time of the
operation which should not be revised in the light of subsequent
histopathology reporting. |
Code List |
1 |
Curative |
R |
N/A |
2 |
Palliative | |||||
3 |
Uncertain | |||||
Immediate Post Operative Care |
To determine immediate post operative care requirements for the patient |
Code List |
1 |
Standard Ward Care |
R |
N/A |
2 |
High Care Area | |||||
3 |
Level 2 HDU care | |||||
4 |
Level 3 ICU care | |||||
Colorectal - Pathology. To carry details of pathology for colorectal cancer (May be up to one occurrence of this group per pathology report) | ||||||
Local Invasion Polypoid Tumours (Haggitt level) |
The level of invasion into
the stalk of the polyp |
Code List |
1 |
Haggitt Level 1 - carcinoma invading through muscularis mucosa into submucosa but limited to the head of the polyp |
R |
N/A |
2 |
Haggitt Level 2 - Carcinoma invading the level of the neck of the adenoma | |||||
3 |
Haggitt Level 3 - Carcinoma invading any part of the stalk | |||||
4 |
Haggitt Level 4 - Carcinoma invading into the submucosa of the bowel wall below the stalk of the polyp but above the muscularis propria | |||||
8 |
Haggitt Level - Not applicable/Not assessable | |||||
Local Invasion Sessile Tumours (Kikuchi level) |
The level of sub mucosal
infiltration of the pathological T1 tumour |
Code List |
1 |
Kikuchi Level Sm1 - Invasion of the superficial one-third of the submucosa |
R |
N/A |
2 |
Kikuchi Level Sm2 - Invasion of the middle one-third of the submucosa | |||||
3 |
Kikuchi Level Sm3 - Invasion of the deep one-third of the submucosa | |||||
8 |
Kikuchi Level - Not applicable/Not assessable | |||||
Status of Circumferential Excision Margin |
Record if the edge of the tumour is 1 mm or less from the circumferential resection margin (ie, margin involved). Circumferential margin refers to the completeness of the surgeon’s resection margin in the opinion of the histopathologist. In parts of the colon where it is completely surrounded by peritoneum, recording of the circumferential resection margin (CRM) is not appropriate |
Code List |
0 |
Margin Not Involved |
R |
Status of Circumferential Excision Margin (pCO5300) |
1 |
Margin Involved | |||||
9 |
Not Known | |||||
Distance to Circumferential Margin |
Record the distance from the
outer margin of the tumour to the closest non peritonealised
circumferential resection margin in mm. |
max n2.max n2 |
N/A |
N/A |
R |
Distance to Circumferential Margin (pCO5210) |
Plane of Surgical Excision |
This is the quality of the
surgical excision as seen by the pathologist. This grades the
resection on its worst plane. |
Code List |
1 |
Mesorectal fascia plane |
R |
Plane of Surgical Excision (pCO5260) |
2 |
Intramesorectal plane | |||||
3 |
Muscularis propria plane | |||||
Response to Pre-Operative Therapy |
If preoperative therapy was
given what was the response. |
Code List |
08 |
No viable cancer cells (TRS 0) |
R |
Response to Pre-Operative Therapy (pCO5290) |
09 |
Single cells or rare small groups of cancer cells (TRS 1) | |||||
10 |
Residual cancer with evident tumour regression (TRS 2) | |||||
11 |
No evident tumour regression (TRS 3) | |||||
97 |
Not Applicable | |||||
Positive Proximal or Distal Resection Margin |
Record whether the proximal or distal resection margins were involved. If the minimal distance from the cut margin is less than or equal to 1 mm the margin is considered involved |
Code List |
0 |
Margins not involved |
R |
Positive Proximal or Distal Resection Margin (pCO5190) |
1 |
Margin involved | |||||
8 |
Not submitted by pathologist | |||||
9 |
Not Known | |||||
Distance from Dentate Line |
Record the distance of the
tumour from the dentate line in mm measured on the gross
specimen |
mm (max n3.max n2) |
N/A |
N/A |
R |
Distance from Dentate Line (pCO5270) |
Distance Beyond Muscularis Propria |
Maximum distance of spread beyond muscularis propria in mm. If there is doubt about the sites of the muscularis propria estimate the distance as accurately as possible |
mm (max n3.max n2) |
N/A |
N/A |
R |
Distance Beyond Muscularis Propria (pCO5280) |
Tumour Regression Grade |
Record the tumour regression
grade. |
Code List |
1 |
Grade 1 - Complete regression, no viable tumour cells, fibrosis extending through bowel wall |
R |
N/A |
2 |
Grade 2 - Isolated single cell or small clusters of tumour cells scattered through fibrosis | |||||
3 |
Grade 3 - Fibrosis predominates, outgrowing residual tumour | |||||
4 |
Grade 4 - Residual tumour outgrows fibrosis | |||||
5 |
Grade 5 - Extensive residual tumour without fibrosis | |||||
Grade of Differentiation (Pathological) * |
Grade of Differentiation
(Pathological) is the definitive grade of the tumour based on the evidence
from a pathological examination |
Code List |
G1 |
Well differentiated |
R |
Grade of Differentiation (Pathological) (pCR0860) |
G3 |
Poorly differentiated | |||||
Colorectal - Treatment. To carry details of certain treatments for colorectal cancer (May be up to one occurrence of this group per treatments given) | ||||||
Biological/Immunological Treatment Given |
Record the specific Biological/Immunological treatment given |
Code List |
1 |
Cetuximab |
R |
N/A |
2 |
Bevacizumab | |||||
3 |
Pantimumab | |||||
7 |
Other | |||||
Other Biological/Immunological Treatment given |
If Other is recorded for data item Biological/Immunological Treatment Given, please specify the biological/immunological treatment given |
max an50 |
N/A |
N/A |
R |
N/A |
Biomarkers (One occurrence of this group per Core) | ||||||
Dihydropyrimidine Dehydrogenase (DPD) Performed |
Record if DPD test was performed |
Code List |
Y |
Yes |
R |
N/A |
N |
No | |||||
Dihydropyrimidine Dehydrogenase (DPD) Status |
To record the DPD Status for
the patient, if performed |
Code List |
1 |
DPYP variant homozygous |
R |
N/A |
2 |
DPYP variant heterozygous | |||||
3 |
No variant detected | |||||
9 |
Not known | |||||
Vascular Endothelial Growth Factor (VEGF) Status |
Select the recorded outcome for the VEGF Mutational status. |
Code List |
07 |
Wild Type |
R |
N/A |
08 |
Sensitising/activating mutation(s) only | |||||
09 |
Resistance mutation - with or without other mutation | |||||
98 |
Not Applicable (Not Assessed) | |||||
99 |
Not Known (Failed Analysis) | |||||
KRAS Status |
Select the recorded outcome for the KRAS Mutational status. |
Code List |
07 |
Wild Type |
R |
N/A |
08 |
Sensitising/activating mutation(s) only | |||||
09 |
Resistance mutation - with or without other mutation | |||||
98 |
Not Applicable (Not Assessed) | |||||
99 |
Not Known (Failed Analysis) | |||||
NRAS Status |
Select the recorded outcome for the NRAS Mutational status. |
Code List |
07 |
Wild Type |
R |
N/A |
08 |
Sensitising/activating mutation(s) only | |||||
09 |
Resistance mutation - with or without other mutation | |||||
98 |
Not Applicable (Not Assessed) | |||||
99 |
Not Known (Failed Analysis) | |||||
BRAF Status |
Select the recorded outcome for the BRAF Mutational status. |
Code List |
07 |
Wild Type |
R |
N/A |
08 |
Sensitising/activating mutation(s) only | |||||
09 |
Resistance mutation - with or without other mutation | |||||
98 |
Not Applicable (Not Assessed) | |||||
99 |
Not Known (Failed Analysis) |